The use of glatiramer acetate (copolymer 1) in the treatment...

Details The use of glatiramer acetate (copolymer 1) in the treatment... The use of glatiramer acetate (copolymer 1) in the treatment...

A - Human Necessities

61

K

A61K 9/00 (2006.01) A61F 9/02 (2006.01) A61F 13/00 (2006.01) A61K 31/785 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2411536

The present invention involves the administration of Copolymer 1 (glatiramer acetate) to treat inflammatory, non-autoimmune central nervous system (CNS) diseases, alleviate the symptoms thereof, inhibit the activity of matrix metalloproteinases and suppress cytokine production by T lymphocytes.

L'invention consiste à administrer copolymère I (acétate de glatiramère) afin de traiter des maladies inflammatoires, non auto-immunes du système nerveux central (CNS), d'en soulager les symptômes, d'inhiber l'activité de métalloprotéinases de matrice et de supprimer la production de cytokines par les lymphocytes T.

Affiliated with

Also associated with

Rating

The use of glatiramer acetate (copolymer 1) in the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The use of glatiramer acetate (copolymer 1) in the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of glatiramer acetate (copolymer 1) in the treatment... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1629178